Navigation Links
Formedix to Host Executive Breakfast prior to Bay Area CDISC Network Meeting, May 23, 2013
Date:5/8/2013

Burlington, MA (PRWEB) May 08, 2013

Formedix, a leading provider of CDISC based clinical trial automation software and consultancy services, is hosting an executive breakfast on May 23, 2013 from 9 am, prior to the Bay Area CDISC Network Meeting, this year sponsored by Formedix. The event is being held in the South San Francisco Conference Center.

Mark Wheeldon, of Formedix, will be joined at the morning event by CEO of CDISC Rebecca Kush and David Borbas, Senior Director of Data Management at Jazz Pharmaceuticals for presentations celebrating CDISC standards and their use within the clinical trial process. The breakfast will provide attendees with the opportunity to hear industry specialists’ opinions on CDISC standards and their application throughout a clinical trial, as well as the chance to enjoy high-level networking.

The executive breakfast will lead up to the Bay Area CDISC Network Meeting, to be held at 1 pm in the same location, where Mark Wheeldon, CEO of Formedix, this year’s event sponsor, will also be presenting all about Define-XML and the business benefits of using this standard in your clinical trials.

Mark Wheeldon says, “Formedix is delighted to be sponsoring this year’s Bay Area CDISC Network Meeting, as well as to be back presenting at the event. We also relish the opportunity to be able to host our own executive breakfast meeting prior to the event to hear from other industry specialists and meet with life science industry members to discuss CDISC standards and how others are currently working with them.”

He also adds, “CDISC Standards are vendor-neutral and portable; they can be reused across a whole trial across multiple platforms so we are always interested to find out where people are using them and offer our help and advice.”

For more information and to register for the free networking event, visit the event page. The invitation is open to any interested industry professionals at any point in their CDISC adoption cycle, as well as those in the area to attend the Bay Area CDISC User Group in the afternoon.

About Formedix

Formedix clinical trial automation software and services enable you to remove manual, expensive, inefficient and labor intensive tasks from study set-up, EDC build, validation and submission publication processes.

In fact, across every area of your end-to-end clinical trial, the time and cost savings they deliver speak for themselves and continue to do so time and time again.

Formedix saves 68% in set-up time and 55% in EDC build time. With 70% reuse of your content, resources are cut by 23%. It’s all in the numbers.

Your Clinical Trials Automated. Everywhere.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10713648.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. "Collaborate to Innovate" with Formedix at DIA Annual Meeting 2012
2. Formedix Partners with Perceptive Informatics for Forthcoming Webcast, “Four Secrets to Using CDISC Standards to Enable Clinical Trial Efficiencies”
3. Formedix to Host Webinar: Discover Define-XML - Practical Uses Today and a Technical Deep Dive on March 14, 2013
4. Formedix and OmniComm Partner to Offer CRO and Sponsors Multi-Vendor EDC Capabilities
5. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
6. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
7. GenVec President and Chief Executive Officer Announces Retirement
8. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
9. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
10. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
11. Silence Therapeutics Announces Board Changes and Appointment of New Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... , ... August 16, 2017 , ... ... microbe delivery system, announced it has secured $2M in funding from an impressive ... Angels, Carmen Innovations, and SVG Thrive Fund. With this investment, 3Bar is broadening ...
(Date:8/15/2017)... ... ... Kapstone Medical is proud to announce that it has reached ... inventors develop and safeguard their latest innovations. The company has grown from a ... clients in the United States and around the world. , Company Founder and ...
(Date:8/15/2017)... NY (PRWEB) , ... August 15, 2017 , ... ... first time on Immuno-Oncology 360° (IO360°) programming through a series of upcoming panels and ... held February 7-9, 2018, at The Roosevelt Hotel in New York City. , “With ...
(Date:8/14/2017)... ... August 14, 2017 , ... The Conference Forum has confirmed the ... place on September 6, 2017 at the Marriott Copley Place in Boston, MA. , ... Informatics, and Regulatory Strategy, Pfizer Innovative Research Lab, Pfizer, who leads 19 industry speakers ...
Breaking Biology Technology:
(Date:3/30/2017)... LOS ANGELES , March 30, 2017  On ... Hack the Genome hackathon at ... This exciting two-day competition will focus on developing health ... experience. Hack the Genome is ... has been tremendous. The world,s largest companies in the ...
(Date:3/28/2017)... 28, 2017 The report "Video ... Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), and ... Global Forecast to 2022", published by MarketsandMarkets, the market ... is projected to reach USD 75.64 Billion by 2022, ... The base year considered for the study is 2016 ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and ... 2022", published by MarketsandMarkets, the market is expected to be worth USD 18.98 ... Continue Reading ... ...      ...
Breaking Biology News(10 mins):